CID is 5892
synonyms found at PubChem are:
nadide, NAD+, coenzyme I, 53-84-9, beta-NAD, beta-NAD+, diphosphopyridine nucleotide, beta-Diphosphopyridine nucleotide, Enzopride, nicotinamide adenine dinucleotide, Codehydrase I, beta-nicotinamide adenine dinucleotide, Cozymase I, Codehydrogenase I, CO-1, CO-I, NAD, Nadidum [INN-Latin], Nadida [INN-Spanish], beta-DPN, Pyridine, nucleotide diphosphate, Nicotinamide-adenine dinucleotide, NAD zwitterion, COZYMASE, Nicotinamide dinucleotide, Adenine-nicotinamide dinucleotide, NAD+, Free Acid, Nadide [USAN:INN:BAN:JAN], Oxidized diphosphopyridine nucleotide, EINECS 200-184-4, NSC 20272, BRN 3584133, CHEBI:44215, BAWFJGJZGIEFAR-NNYOXOHSSA-N, C21H27N7O14P2, UNII-0U46U6E8UK, MFCD00036253, 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide, 5'-ester with adenosine 5'-pyrophosphate, inner salt, Nicotinamide-Adenine-Dinucleotide, DPN-ox, Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt, Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt, nicotinamide adenine dinucleotide oxidized, DPN+, Nadidum, Nadida, 0U46U6E8UK, [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate, Adenosine 5'-(trihydrogen diphosphate), 5'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, hydroxide, inner salt, Pyridinium, 3-carbamoyl-1-beta-D-ribofuranosyl-, hydroxide, 5'-ester with adenosine 5'-5'-(trihydrogen pyrophosphate), inner salt, diphosphopyridine nucleotide oxidized, beta-Nicotinamide adenine dinucleotide hydrate, NSC20272, CAS-53-84-9, Cozymasei(NAD+), NCGC00016240-01, b-NAD, oxidised form, C-NAD, beta-NAD, oxidised form, 3-carbamoylpyridin-1-ium, Carbonyl [14C] NAD+, D0M3KZ, EC 200-184-4, AC1L1LD0, NAD, Grade I, free acid, [adenylate-32-P]-NAD+, DSSTox_CID_25236, DSSTox_RID_80768, NAD, Grade II, free acid, DSSTox_GSID_45236, 5-26-16-00399 (Beilstein Handbook Reference), SCHEMBL131544, SPECTRUM1500419, beta-Diphosphopyridinenucleotide, GTPL2451, CHEMBL1234613, DTXSID2045236, CTK8B3792, HMS500J11, Nicotinamide Adinine Dinucleotide, MolPort-003-666-238, [14C] NAD+, [32P] NAD+, b-Nicotinamide adenine dinucleotide, BDBM213227, HMS2091H06, HMS2097E04, HMS3714E04, Pharmakon1600-01500419, HY-B0445, Diphosphopyridine nucleotide (DPN+), Tox21_110321, 6614AF, ANW-43201, CCG-40114, NSC757121, s2518, AKOS015892319, beta-nicotinamide adenine din-ucleotide, CM11026, CS-2554, NSC-757121, .beta.-Nicotinamide adenine dinucleotide, Nicotinamide adenine dinucleotide (NAD), NCGC00178839-01, NCGC00178839-02, AS-14652, M041, SBI-0051451.P003, AB2000620, LS-132322, TR-019029, AB00513910, D0919, beta-Nicotinamide adenine dinucleotide, reduced, N-2550, AB00052048_03, b-Nicotinamide adenine dinucleotide hydrate (NAD), I02-6267, Nicotinamide adenine dinucleotideNAD+mono sodium salt, beta-Nicotinamide adenine dinucleotide hydrate, >=99%, F45C0D6C-DA87-47BE-9975-7A5DE9CCB985, beta-Nicotinamide adenine dinucleotide hydrate, >=95% (HPLC), beta-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial), beta-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial), beta-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial), beta-Nicotinamide adenine dinucleotide hydrate, >=98%, BioUltra, from yeast, beta-Nicotinamide adenine dinucleotide hydrate, Grade AA-1, >=95% (HPLC), beta-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, >=99%, beta-Nicotinamide adenine dinucleotide hydrate, Vetec(TM) reagent grade, >=96.5%, [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl)hydrogen phosphate, [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate, 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-, 1083039-67-1, 1354693-98-3, 159929-29-0, 30429-30-2, Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt, Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt, Adenosine 5'-(trihydrogen diphosphate-P-32P), P'>5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt (9CI), adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] hydrogen diphosphate}, beta-Nicotinamide adenine dinucleotide hydrate, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast, beta-Nicotinamide adenine dinucleotide hydrate, cell culture tested, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast, beta-Nicotinamide adenine dinucleotide hydrate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production., beta-Nicotinamide adenine dinucleotide hydrate, Suitable for manufacturing of diagnostic kits and reagents, Pyridinium, 3-carbamoyl-1-b-D-ribofuranosyl-, hydroxide, 5'-5'-ester with adenosine 5'-(trihydrogen pyrophosphate), inner salt (8CI), AC1NRCGS, D0R6JE, [[(2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate